New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis

Yufan Liu, Kexin Cong, Qiao Li, Dan Zhang, Jiyao Sheng · 2025

Read New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis by Yufan Liu, Kexin Cong, Qiao Li, Dan Zhang, Jiyao Sheng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12756107.txt.

Description

Yufan Liu and co-authors review why liver scarring blunts immune therapy for liver cancer and how combination plans might break through, in work from twenty twenty-five. Most liver cancers grow on cirrhotic livers, where chronic inflammation and immune failure build a suppressive neighborhood. Checkpoint drugs answer in only a minority of patients.

The review maps how cirrhosis rewires the liver's immune cells: dendritic cells, T cells, macrophages, and neutrophils shift in count, function, and metabolism. Each shift helps shield the tumor. Candidate targets and pairing strategies aim to correct those faults. The authors frame the cirrhotic microenvironment as the next frontier for raising response rates.

Catalog record

CREATORYufan Liu, Kexin Cong, Qiao Li, Dan Zhang, Jiyao Sheng
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12756107

Browse the full library · About the Tower of Babel